Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for bleeding control in pelvic trauma
IRCT20130710013947N7Phase 2Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tranexamic acid in Pelvic Trauma (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoint: Control of bleeding of pelvic trauma. Started Jan 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Pelvic Trauma
Beyond the preview
Go deeper on IRCT20130710013947N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130710013947N7.